Literature DB >> 26828906

Prevalence and determinants of fatigue in patients with moderate to severe chronic GvHD.

A Im1, S A Mitchell2, S M Steinberg3, L Curtis4, A Berger5, K Baird6, Z Kuzmina7, G Joe8, L E Comis8, M Juckett9, D Avila4, J Baruffaldi10, L Masuch4, F Pirsl4, S Z Pavletic4.   

Abstract

Although fatigue is common after allogeneic hematopoietic cell transplantation, little is known about fatigue in patients with chronic GvHD (cGvHD). The aim of this study was to explore factors associated with fatigue in cGvHD. Data were drawn from a sequentially recruited, cross-sectional study of adults with moderate or severe cGvHD (n=263). Respondents were classified as fatigued or not fatigued based on their response to a single item regarding loss of energy from the Lee cGvHD Symptom Scale. In univariate analysis, factors significantly associated with fatigue included performance status, number of prior cGvHD therapies, cGvHD symptom bother, self-assessed physical and mental health, nutritional status, walk velocity and self-reported physical activity. There were no significant associations between fatigue and disease-related cGvHD variables. Multivariable logistic regression demonstrated that being less active and having pulmonary and/or muscle/joint symptoms were independently associated with fatigue. In conclusion, clinically significant fatigue was prevalent in more than one-third of subjects with cGvHD, and was disabling. Absence of association with measures of cGvHD severity underscores the need to elucidate the pathogenesis of fatigue and its relationship with inflammatory activity. Pulmonary and muscle/joint symptoms and physical inactivity represent potential targets for intervention in clinical studies.

Entities:  

Mesh:

Year:  2016        PMID: 26828906      PMCID: PMC7511994          DOI: 10.1038/bmt.2015.320

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  58 in total

1.  Organ-specific management and supportive care in chronic graft-versus-host disease.

Authors:  Fiona L Dignan; Julia J Scarisbrick; Jacqueline Cornish; Andrew Clark; Persis Amrolia; Graham Jackson; Prem Mahendra; Peter C Taylor; Pallav Shah; Sue Lightman; Farida Fortune; Christopher Kibbler; Jervoise Andreyev; Assunta Albanese; Nedim Hadzic; Michael N Potter; Bronwen E Shaw
Journal:  Br J Haematol       Date:  2012-04-26       Impact factor: 6.998

2.  Norman Cousins Lecture. Mechanisms of cytokine-induced behavioral changes: psychoneuroimmunology at the translational interface.

Authors:  Andrew H Miller
Journal:  Brain Behav Immun       Date:  2008-09-03       Impact factor: 7.217

3.  Identifying clinically meaningful fatigue with the Fatigue Symptom Inventory.

Authors:  Kristine A Donovan; Paul B Jacobsen; Brent J Small; Pamela N Munster; Michael A Andrykowski
Journal:  J Pain Symptom Manage       Date:  2008-05-20       Impact factor: 3.612

4.  Symptom distress predicts long-term health and well-being in allogeneic stem cell transplantation survivors.

Authors:  Margaret F Bevans; Sandra A Mitchell; John A Barrett; Michael R Bishop; Richard Childs; Daniel Fowler; Michael Krumlauf; Patricia Prince; Nonniekaye Shelburne; Leslie Wehrlen; Li Yang
Journal:  Biol Blood Marrow Transplant       Date:  2013-12-17       Impact factor: 5.742

Review 5.  A systematic review of the Human Activity Profile.

Authors:  Megan Davidson; Natalie de Morton
Journal:  Clin Rehabil       Date:  2007-02       Impact factor: 3.477

6.  Weight loss and malnutrition in patients with chronic graft-versus-host disease.

Authors:  D A Jacobsohn; J Margolis; J Doherty; V Anders; G B Vogelsang
Journal:  Bone Marrow Transplant       Date:  2002-02       Impact factor: 5.483

7.  Comparison of SF-36 vitality scale and Fatigue Symptom Inventory in assessing cancer-related fatigue.

Authors:  Linda F Brown; Kurt Kroenke; Dale E Theobald; Jingwei Wu
Journal:  Support Care Cancer       Date:  2011-04-10       Impact factor: 3.603

8.  Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapse.

Authors:  Stephanie J Lee; John P Klein; A John Barrett; Olle Ringden; Joseph H Antin; Jean-Yves Cahn; Matthew H Carabasi; Robert Peter Gale; Sergio Giralt; Gregory A Hale; Osman Ilhan; Philip L McCarthy; Gerard Socie; Leo F Verdonck; Daniel J Weisdorf; Mary M Horowitz
Journal:  Blood       Date:  2002-07-15       Impact factor: 22.113

9.  A prospective study of health-related quality of life, fatigue, anxiety and depression 3-5 years after stem cell transplantation.

Authors:  M J Hjermstad; H Knobel; L Brinch; P M Fayers; J H Loge; H Holte; S Kaasa
Journal:  Bone Marrow Transplant       Date:  2004-08       Impact factor: 5.483

Review 10.  Cancer-related fatigue and its associations with depression and anxiety: a systematic review.

Authors:  Linda F Brown; Kurt Kroenke
Journal:  Psychosomatics       Date:  2009 Sep-Oct       Impact factor: 2.386

View more
  4 in total

1.  Fatigue predicts impaired social adjustment in survivors of allogeneic hematopoietic cell transplantation (HCT).

Authors:  Jumin Park; Leslie Wehrlen; Sandra A Mitchell; Li Yang; Margaret F Bevans
Journal:  Support Care Cancer       Date:  2018-08-22       Impact factor: 3.603

2.  The safety and tolerability of pirfenidone for bronchiolitis obliterans syndrome after hematopoietic cell transplant (STOP-BOS) trial.

Authors:  Efthymia Iliana Matthaiou; Husham Sharifi; Christian O'Donnell; Wayland Chiu; Clark Owyang; Paulami Chatterjee; Ihsan Turk; Laura Johnston; Theresa Brondstetter; Karen Morris; Guang-Shing Cheng; Joe L Hsu
Journal:  Bone Marrow Transplant       Date:  2022-05-31       Impact factor: 5.174

3.  Clinical characterization and cytokine profile of fatigue in hematologic malignancy patients with chronic graft-versus-host disease.

Authors:  Sencer Goklemez; Leorey N Saligan; Filip Pirsl; Noa G Holtzman; Alen Ostojic; Seth M Steinberg; Frances T Hakim; Jeremy J Rose; Zhigang Kang; Yunkai Yu; Liang Cao; Sandra A Mitchell; Annie Im; Steven Z Pavletic
Journal:  Bone Marrow Transplant       Date:  2021-08-25       Impact factor: 5.483

Review 4.  Burden and Needs of Patients with Severe GvHD from the Supportive and Palliative Care Perspective-A Literature Review.

Authors:  Freya Wenzel; Anne Pralong; Udo Holtick; Christoph Scheid; Marco Herling; Steffen T Simon
Journal:  Cancers (Basel)       Date:  2021-05-30       Impact factor: 6.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.